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Background/introduction
For many years, immune activation following tumor abla-
tion has been evaluated in the treatment of systemic cancer.
Ultrasound ablation is thought to promote dendritic cell
maturation and T-cell immunity, and is particularly advan-
tageous because it is non-invasive, can be controlled with
high spatial precision and uses no harmful ionizing
radiation.
Methods
Recently, immune adjuvants have been shown to be effec-
tive in treating metastatic cancer, with cancer immu-
notherapy named as the “breakthrough of the year” in
2013. At this time, combining ablation with immune adju-
vants is a promising technique for expanding the utility of
ultrasound for the treatment of systemic disease. We will
briefly review the status of this combined therapy and
opportunities for future studies.
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